Analysis of response to infliximab in ankylosing spondylitis according to the axial and/or peripheral involvement: autoantibodies and drop outs are more frequent in the peripheral subset.

Ann Rheum Dis

Published: March 2007

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855993	PMC
http://dx.doi.org/10.1136/ard.2006.065052	DOI Listing

Publication Analysis

analysis response

response infliximab

infliximab ankylosing

ankylosing spondylitis

spondylitis axial

axial and/or

and/or peripheral

peripheral involvement

involvement autoantibodies

autoantibodies drop

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!